These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Features and Treatment Effects on Keratoepitheliopathy for Meibomitis-Related Keratoconjunctivitis. Sonomura Y; Yokoi N; Komuro A; Kato H; Sotozono C Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472959 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction. Shimazaki J; Kito G; Kamoi M; Satake Y Jpn J Ophthalmol; 2024 Sep; 68(5):472-481. PubMed ID: 39002075 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Opitz DL; Tyler KF Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761 [TBL] [Abstract][Full Text] [Related]
7. Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study. Suzuki T; Morishige N; Arita R; Koh S; Sakimoto T; Shirakawa R; Miyata K; Ohashi Y BMC Ophthalmol; 2016 Oct; 16(1):178. PubMed ID: 27724848 [TBL] [Abstract][Full Text] [Related]
8. Phlyctenular keratitis associated with meibomitis in young patients. Suzuki T; Mitsuishi Y; Sano Y; Yokoi N; Kinoshita S Am J Ophthalmol; 2005 Jul; 140(1):77-82. PubMed ID: 15953578 [TBL] [Abstract][Full Text] [Related]
10. Dual Role of Suzuki T; Kinoshita S Microorganisms; 2024 Aug; 12(8):. PubMed ID: 39203490 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Luchs J Adv Ther; 2008 Sep; 25(9):858-70. PubMed ID: 18781287 [TBL] [Abstract][Full Text] [Related]
12. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis. Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337 [TBL] [Abstract][Full Text] [Related]
14. Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction. Balci O; Gulkilik G Clin Exp Optom; 2018 Jan; 101(1):18-22. PubMed ID: 28677153 [TBL] [Abstract][Full Text] [Related]
15. The Microbiome of Meibomian Gland Secretions from Patients with Internal Hordeolum Treated with Hypochlorous Acid Eyelid Wipes. Yang S; Wu BC; Cheng Z; Li L; Zhang YP; Zhao H; Zeng HM; Qi DF; Ma ZY; Li JG; Han R; Qu FZ; Luo Y; Liu Y; Chen XL; Dai HM Dis Markers; 2022; 2022():7550090. PubMed ID: 35251376 [TBL] [Abstract][Full Text] [Related]
16. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease. Zhang L; Su Z; Zhang Z; Lin J; Li DQ; Pflugfelder SC JAMA Ophthalmol; 2015 Oct; 133(10):1117-23. PubMed ID: 26204109 [TBL] [Abstract][Full Text] [Related]
17. Meibomitis-related keratoconjunctivitis in childhood and adolescence. Suzuki T; Kinoshita S Am J Ophthalmol; 2007 Jul; 144(1):160-1; author reply 161. PubMed ID: 17601450 [No Abstract] [Full Text] [Related]
18. Oral azithromycin for the treatment of meibomitis. Greene JB; Jeng BH; Fintelmann RE; Margolis TP JAMA Ophthalmol; 2014 Jan; 132(1):121-2. PubMed ID: 24201556 [No Abstract] [Full Text] [Related]